Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight photodynamic therapy with two skin preparation modalities for actinic keratosis
2016-000490-20Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Jun 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of methyl aminolevulinate in actinic keratosis (AK) (2 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoint: Total count of actinic keratoses before and after treatment. Started Jun 2021; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2016-000490-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000490-20.